In June 2025, Eyenovia (EYEN), a once-struggling ophthalmic tech company, shocked financial markets by announcing a bold pivot into the world of decentralized finance (DeFi). The catalyst? A $50 million PIPE (Private Investment in Public Equity) deal aimed at funding the acquisition of Hyperliquid’s native token, HYPE—a move that sent EYEN’s stock soaring over 300% in days. By mid-July, the company rebranded as Hyperion DeFi, with its ticker shifting to HYPD, symbolizing a full transformation from near-bankruptcy to crypto-native ambition.
This unprecedented shift raises critical questions: What drives a traditional biotech firm to bet everything on a relatively new blockchain token? Who is behind this radical strategy? And could HYPE become the next-generation treasury asset for public companies?
Let’s explore how Eyenovia leveraged Hyperliquid, HYPE tokenomics, and strategic DeFi integration to rewrite its future—and what it means for the evolving relationship between Wall Street and Web3.
From Near-Delisting to Hyperliquid Bet: A Turnaround Story
Eyenovia was founded in 2018 with promising micro-dosing eye treatment devices, including Optejet for post-surgery care and myopia management. But despite early hype, revenue collapsed—reaching just $56,000 in 2024 while posting a $50 million net loss. By April 2025, its stock dipped below $1, putting it at risk of delisting from Nasdaq.
Then came the turnaround.
On June 17, Eyenovia announced a $50 million PIPE investment from institutional accredited investors, explicitly earmarked for acquiring **HYPE tokens**. The market reacted instantly: shares surged 134% the next day. Within days, Eyenovia purchased over 1 million HYPE tokens at an average price of $34 each, now held securely via Anchorage Digital.
👉 Discover how public companies are reshaping their balance sheets with next-gen crypto assets.
This wasn't just a speculative play—it was a structural reinvention. Alongside the purchase, Eyenovia issued 15.4 million convertible preferred shares and 30.8 million warrant shares (exercise price: $3.25), potentially unlocking up to $150 million in additional capital if fully exercised. The goal? To become the largest publicly traded holder of HYPE—a title that could redefine corporate treasury strategies in the DeFi era.
Meet Hyunsu Jung: The Architect Behind the Crypto Pivot
Central to this transformation is Hyunsu Jung, Eyenovia’s newly appointed Chief Investment Officer and board member. Offered 500,000 common shares as incentive, Jung brings deep roots in both traditional finance and decentralized ecosystems.
His career began at EY-Parthenon, advising on major M&A deals like United Technologies’ spin-off. But disillusioned by corporate inertia, he jumped into crypto in 2021—joining DARMA Capital, a digital asset advisory co-founded by ConsenSys’ Andrew Keys.
At DARMA, Jung led the development of FAUS, a CFTC-approved derivative product that lowered financial barriers for Filecoin (FIL) miners. The protocol eventually deployed over $300 million across 50+ data centers globally—a testament to his ability to bridge institutional rigor with blockchain innovation.
Jung’s connection to Hyperliquid runs deeper than professional interest. He’s long been close with MAX, a core contributor to Hyperliquid, dating back to their student days in Edinburgh and shared early crypto experiments in San Juan. This personal trust likely accelerated Eyenovia’s alignment with Hyperliquid’s vision.
Beyond Holding: Building a DeFi Revenue Engine
While many firms simply "buy and hold" crypto, Eyenovia plans to generate active income through multiple DeFi channels:
- Staking & Node Operations: On June 25, Eyenovia launched Kinetiq x Hyperion, a joint validator node with Hyperliquid’s native staking protocol Kinetiq. Backed by Pier Two, an institutional-grade node operator, this setup earns yield directly from network fees.
- Liquidity Provision & Referral Incentives: The company may engage in LP staking and leverage Hyperliquid’s referral system to earn fee rebates—without exposing itself to HYPE price volatility.
- Future DeFi Integration: Though not building its own dApps yet, Eyenovia plans to evaluate opportunities in LST liquidity pools, lending protocols, and structured products on HyperEVM.
Hyunsu envisions a closed-loop asset management model inspired by MicroStrategy but evolved for DeFi:
“Imagine a treasury where stablecoin deposits mint two types of tokens: one representing principal (CDT bond token), another granting future upside (Options NFT). This allows compounding returns while maintaining liquidity and risk control.”
Such innovation positions Eyenovia not just as a passive investor—but as a strategic participant in Hyperliquid’s growth flywheel.
Why HYPE? The Case for a New Treasury Asset
With Bitcoin and Ethereum already adopted by firms like MicroStrategy and SharpLink, why did Eyenovia choose HYPE?
According to Jung, three factors make HYPE uniquely suited as a treasury reserve:
1. Deflationary Tokenomics
Unlike BTC (fixed supply) or ETH (moderate deflation), HYPE features an automatic fee-burning mechanism: every transaction on Hyperliquid triggers a buyback-and-burn of HYPE tokens. As of June 2025, over 25 million HYPE tokens have been permanently removed from circulation—creating structural scarcity.
2. Productive Utility
Holding HYPE isn’t passive. Stakers receive:
- Reduced trading fees
- Governance rights
- Eligibility for node validation rewards
This makes HYPE a true productive asset, generating recurring revenue streams beyond price appreciation.
3. High Growth Narrative
Hyperliquid has emerged as one of the fastest-growing perpetuals platforms, ranking among the top 10 blockchains by TVL. Its user base and daily volume continue rising—tying HYPE’s value directly to real-world usage rather than speculation alone.
👉 See how emerging tokens are creating new paths for corporate treasury innovation.
As Jung puts it:
“HYPE offers exposure to a high-growth, utility-driven ecosystem that traditional investors can understand. It’s not just another speculative coin—it’s equity-like participation in a decentralized exchange.”
Addressing the Elephant in the Room: Is This Just Exit Liquidity?
Critics argue that Eyenovia’s massive buy-in might serve as an exit ramp for early HYPE whales. But Jung pushes back:
- All initial airdrops are already unlocked; only core team allocations remain locked until November 2025.
- MAX confirms no large-scale sell-offs are planned by insiders.
- Eyenovia bought HYPE entirely on the open market—absorbing existing supply rather than facilitating private exits.
Moreover, the company has implemented risk mitigation strategies:
- Diversified revenue models tied to staking yields (less dependent on price)
- Potential use of derivatives to hedge downside exposure
- Transparent custody via regulated entities like Anchorage
These measures aim to protect shareholder value even during market downturns.
Could This Be the Future of Public Company Strategy?
Eyenovia’s pivot mirrors earlier successes:
- MicroStrategy: Turned $BTC into a $100B+ valuation story
- SharpLink Gaming: Rose 500% after announcing ETH purchases
But Eyenovia goes further—it’s not just holding crypto; it’s actively participating in protocol economics.
If Hyperliquid continues growing, and HYPE maintains deflationary pressure and utility demand, Eyenovia could pioneer a new class of publicly traded DeFi-integrated firms.
Of course, risks remain:
- Regulatory scrutiny over crypto holdings
- Volatility in HYPE’s price
- Competition from centralized exchanges like Coinbase and Robinhood entering perpetuals
Yet, as more institutions explore on-chain assets—from BlackRock’s tokenized funds to PayPal’s stablecoin—the line between traditional finance and DeFi is blurring.
👉 Explore how institutional adoption is reshaping the future of digital assets.
Frequently Asked Questions (FAQ)
Q: What is Eyenovia’s new name and ticker?
A: As of July 3, 2025, Eyenovia officially rebranded to Hyperion DeFi, with its Nasdaq ticker changed to HYPD.
Q: How many HYPE tokens did Hyperion DeFi buy?
A: The company acquired 1,040,584.5 HYPE tokens at an average cost of $34 per token.
Q: Is HYPE similar to Bitcoin or Ethereum as a treasury asset?
A: No. While BTC is primarily a store of value and ETH supports smart contracts, HYPE is designed as a productive, deflationary asset with built-in yield mechanisms via staking and fee burns.
Q: Does Hyperion DeFi plan to build its own DeFi apps?
A: Not currently. The focus is on being an active investor and validator within Hyperliquid’s ecosystem, particularly in LSTs and lending markets.
Q: Could this strategy fail if HYPE loses value?
A: Yes—like any crypto investment, there’s volatility risk. However, Hyperion DeFi employs staking-based income and potential hedging tools to reduce reliance on price appreciation alone.
Q: Is this legal for a U.S. public company?
A: Yes. So long as purchases are disclosed and compliant with SEC regulations—and custodied through licensed providers like Anchorage—public companies can hold digital assets on their balance sheets.
The story of Eyenovia is no longer about eye drops—it’s about reimagining corporate survival through blockchain innovation. By embracing HYPE, Hyperliquid, and active DeFi participation, Hyperion DeFi may have found more than a lifeline: it may have discovered the blueprint for the next generation of publicly traded companies.